7th Annual AI in Drug Discovery Conference

7th Annual AI in Drug Discovery Conference is organized by SAE Media Group (SMG) and will be held from Mar 09 - 10, 2026 at Hilton London Kensington, London, England, United Kingdom.

Description:
With ever-increasing pressures on drug pipelines, strategies for faster, cheaper and more successful R&D are required – this conference will showcase how AI-driven technologies are turning these strategies into reality. Through detailed case-study presentations and interactive panel-discussion sessions, we will navigate data volume and quality challenges, create strategies for increasing efficiency of R&D, and explore the impact of generative AI on drug discovery pipelines.

This year’s event will feature hot topics including applications of AI/ML within target identification and computational drug design, the impact of generative AI on ways of working and clinical updates from the first AI-designed drug candidates.

Our two-day agenda offers you peer-to-peer networking with industry experts from an extensive selection of big pharma and breakthrough biotech’s in the field, including directors and heads of informatics, data & AI, molecular design, and computational chemistry. Don’t miss the chance to hear the latest advancements from leaders in the industry!

Speakers: Peter Clark, VP Computational Drug Design, Novo Nordisk (Chair), James Lumley, Head of Cheminformatics, GSK, Le (Muller) Mu, MLOps Lead, Computational Sciences Centre of Excellence, gRED, Roche, Dr. Pedro J Ballester, Royal Society Wolfson Fellow and Associate Professor, Department of Bioengineering, Imperial College, University of London, Thierry Dorval  Head of Data Science and Data Management, Servier, Lewis Vidler, Senior Director – Structure Based Drug Design, Eli Lilly and Company, Tim Hohm, Associate Director, Digital Science Ext Partnerships, Novo Nordisk, Graeme Robb, Director, Computational Chemistry, AstraZeneca, Haruna Iwaoka, Head, Advanced Modelling and Assays, Innovation Lab, Astellas Pharma, Reiko Wada, Senior Scientist, Astellas Pharma, Anna Macintyre, Senior Data Scientist, Novo Nordisk, Krishna Bulusu, Senior Director, Oncology Data Science, AstraZeneca, Simone Fulle, Head CADD, Novartis (Basel), Martin Redhead, Associate VP, Primary Pharmacology, Recursion, Paul Mortenson, Senior Director, Computational Chemistry and Informatics, Astex Pharmaceuticals, Teresa De Haro, Principal Scientist, UCB, Martin Buttenschoen, Researcher, Oxford Protein Informatics Group, University of Oxford, Venkatesh Pilla Reddy, Senior Director, Global PKPD and Pharmacometrics, Eli Lilly, Christoph Grebner, AI Scientist and Computational Chemist, Sanofi, Sammeli Liikkanen, Director, Digital Medicine, Orion Pharma, Dr Yogesh Sabnis, Lead Chemist, UCB, Dr Petrina Kamya, Global Head of AI Platforms, VP, Insilico Medicine / Insilico Canada Inc.